These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36732631)

  • 21. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
    Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
    Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay of condensation and chromatin binding underlies BRD4 targeting.
    Strom AR; Eeftens JM; Polyachenko Y; Weaver CJ; Watanabe HF; Bracha D; Orlovsky ND; Jumper CC; Jacobs WM; Brangwynne CP
    Mol Biol Cell; 2024 Jun; 35(6):ar88. PubMed ID: 38656803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis.
    Wang Y; Zhu Y; Gu Y; Ma M; Wang Y; Qi S; Zeng Y; Zhu R; Wang X; Yu P; Xu J; Shu Y; Yu FX
    Cell Rep; 2021 Aug; 36(8):109596. PubMed ID: 34433060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP1 fusion-positive supratentorial ependymoma in an infant: clinical, imaging and therapeutic considerations for a rare entity.
    Henriques V; Soares JG; Costa JA
    BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 39038871
    [No Abstract]   [Full Text] [Related]  

  • 25. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
    Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
    Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.
    Mesrouze Y; Bokhovchuk F; Meyerhofer M; Fontana P; Zimmermann C; Martin T; Delaunay C; Erdmann D; Schmelzle T; Chène P
    Elife; 2017 Apr; 6():. PubMed ID: 28430104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD.
    Nishimoto M; Uranishi K; Asaka MN; Suzuki A; Mizuno Y; Hirasaki M; Okuda A
    Sci Rep; 2019 Jul; 9(1):10933. PubMed ID: 31358774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
    Yu M; Peng Z; Qin M; Liu Y; Wang J; Zhang C; Lin J; Dong T; Wang L; Li S; Yang Y; Xu S; Guo W; Zhang X; Shi M; Peng H; Luo X; Zhang H; Zhang L; Li Y; Yang XP; Sun S
    Mol Cell; 2021 Mar; 81(6):1216-1230.e9. PubMed ID: 33606996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
    Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
    Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Abl antagonizes the YAP oncogenic function.
    Keshet R; Adler J; Ricardo Lax I; Shanzer M; Porat Z; Reuven N; Shaul Y
    Cell Death Differ; 2015 Jun; 22(6):935-45. PubMed ID: 25361080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
    Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
    Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
    Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
    Elife; 2021 Apr; 10():. PubMed ID: 33913810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YAP-mediated induction of monoacylglycerol lipase restrains oncogenic transformation.
    Tang ED; Wang CY
    Cell Signal; 2015 Apr; 27(4):836-40. PubMed ID: 25636199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
    Li H; Gumbiner BM
    Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concerted localization-resets precede YAP-dependent transcription.
    Franklin JM; Ghosh RP; Shi Q; Reddick MP; Liphardt JT
    Nat Commun; 2020 Sep; 11(1):4581. PubMed ID: 32917893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.
    Liu-Chittenden Y; Huang B; Shim JS; Chen Q; Lee SJ; Anders RA; Liu JO; Pan D
    Genes Dev; 2012 Jun; 26(12):1300-5. PubMed ID: 22677547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.